Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. EHC
stocks logo

EHC

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
1.54B
+9.65%
1.302
+11.28%
1.58B
+8.85%
1.497
+9.23%
1.58B
+8.66%
1.473
+5.22%
Estimates Revision
The market is revising Downward the revenue expectations for Encompass Health Corporation (EHC) for FY2025, with the revenue forecasts being adjusted by -0.06% over the past three months. During the same period, the stock price has changed by -3.63%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.06%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+0.57%
In Past 3 Month
Stock Price
Go Down
down Image
-3.63%
In Past 3 Month
Wall Street analysts forecast EHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EHC is 142.57 USD with a low forecast of 134.00 USD and a high forecast of 160.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Analyst Rating
Wall Street analysts forecast EHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EHC is 142.57 USD with a low forecast of 134.00 USD and a high forecast of 160.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Buy
0 Hold
0 Sell
Strong Buy
Current: 114.800
sliders
Low
134.00
Averages
142.57
High
160.00
Current: 114.800
sliders
Low
134.00
Averages
142.57
High
160.00
Barclays
Andrew Mok
Overweight
maintain
$141 -> $150
2025-10-30
Reason
Barclays
Andrew Mok
Price Target
$141 -> $150
2025-10-30
maintain
Overweight
Reason
Barclays analyst Andrew Mok raised the firm's price target on Encompass Health to $150 from $141 and keeps an Overweight rating on the shares. The company reported a modest Q4 beat, the analyst tells investors in a research note.
KeyBanc
Overweight
maintain
$135 -> $140
2025-09-16
Reason
KeyBanc
Price Target
$135 -> $140
2025-09-16
maintain
Overweight
Reason
KeyBanc raised the firm's price target on Encompass Health to $140 from $135 and keeps an Overweight rating on the shares. The firm recently spent time with Encompass Health's management team at the company's Birmingham headquarters and hosted a group call with investors. KeyBanc believes Encompass Health is well positioned to sustain attractive growth, given IRF supply-demand dynamics and visible market share opportunities. Upside drivers from the first half of the year seem sustainable to us, including the favorable mix of VA patients. Policy backdrop for IRFs remains benign. Leverage and free cash flow may support an accelerated pace of buybacks.
BofA
Buy
maintain
$145 -> $160
2025-09-10
Reason
BofA
Price Target
$145 -> $160
2025-09-10
maintain
Buy
Reason
BofA raised the firm's price target on Encompass Health to $160 from $145 and keeps a Buy rating on the shares. While hospital fundamentals should remain solid in the second half, the firm is concerned that the policy and reimbursement environment will be more negative compared to recent years, says the analyst, who prefers post-acute over hospitals as the least exposed to the upcoming cuts given this backdrop. The firm is updating estimates and price targets for several companies in its health care facilities coverage.
Truist
David MacDonald
Buy
maintain
$135 -> $140
2025-08-14
Reason
Truist
David MacDonald
Price Target
$135 -> $140
2025-08-14
maintain
Buy
Reason
Truist analyst David MacDonald raised the firm's price target on Encompass Health to $140 from $135 and keeps a Buy rating on the shares after meeting with management. The firm believes Encompass is seeing "robust" fundamentals due to strong demand trends and its scale. Ongoing labor improvement, increased artificial intelligence investment and the company's development activity further support a bullish stance on shares, the analyst tells investors in a research note.
UBS
Buy
upgrade
$130 -> $140
2025-08-06
Reason
UBS
Price Target
$130 -> $140
2025-08-06
upgrade
Buy
Reason
UBS raised the firm's price target on Encompass Health to $140 from $130 and keeps a Buy rating on the shares. Fundamentals remained strong in Q2, the analyst tells investors in a research note.
Mizuho
Outperform
maintain
2025-07-16
Reason
Mizuho
Price Target
2025-07-16
maintain
Outperform
Reason
Mizuho views the selloff yesterday in shares of Encompass Health following the New York Times report questioning the quality of the company's care as overdone. The article "presents a selective one-sided perspective," the analyst tells investors in a research note. Mizuho says the ten patients mentioned in the article represent less than 0.001% of all Encompass patients since 2021. The firm believes the company's earnings viability remains high and reiterates an Outperform rating on the name. It would buy the stock on the weakness.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Encompass Health Corp (EHC.N) is 20.33, compared to its 5-year average forward P/E of 19.46. For a more detailed relative valuation and DCF analysis to assess Encompass Health Corp 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
19.46
Current PE
20.33
Overvalued PE
21.54
Undervalued PE
17.38

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
11.07
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
11.92
Undervalued EV/EBITDA
10.22

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
2.71
Current PS
114.80
Overvalued PS
14.60
Undervalued PS
-9.19
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

EHC News & Events

Events Timeline

(ET)
2025-10-29
16:24:29
Encompass Health increases FY25 adjusted EPS forecast to $5.22-$5.37, up from $5.12-$5.34
select
2025-10-29
16:22:52
Encompass Health announces Q3 adjusted EPS of $1.23, surpassing consensus estimate of $1.01.
select
2025-08-15 (ET)
2025-08-15
08:31:40
Encompass Health, BSA Health System announce joint venture
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.5
11-11Newsfilter
Amarillo's Rehabilitation Hospital Opens Its Doors in Texas

  • Joint Venture Announcement: Encompass Health and BSA Health System have opened the Rehabilitation Hospital of Amarillo, a 50-bed inpatient rehabilitation facility now accepting patients.

  • Comprehensive Rehabilitation Services: The hospital offers specialized rehabilitation services for patients recovering from various conditions, including strokes and spinal cord injuries, with a focus on personalized treatment plans and intensive therapy.

  • Facility Features: Designed with patient needs in mind, the hospital includes private rooms, advanced therapy technologies, and amenities such as a landscaped therapy courtyard and an in-house pharmacy.

  • Regional Impact: This new facility significantly increases the capacity for inpatient rehabilitation care in the Texas Panhandle, reflecting BSA's commitment to high-quality community health services.

[object Object]
Preview
7.0
11-05Reuters
Conservative Appeals Judge Critiques 'Constitutional Issues' in US Whistleblower Law

  • Judge's Concerns: U.S. Circuit Judge James Ho is advocating for the 5th Circuit to reconsider its precedent regarding the constitutionality of the "qui tam" provision in the False Claims Act, which allows whistleblowers to sue on behalf of the government.

  • Case Background: The case involves a lawsuit against Encompass Health Rehabilitation Hospital, where a former employee alleged false claims to Medicare, but the court upheld the dismissal due to insufficient evidence.

  • Judicial Opinions: Ho's opinion reflects a growing concern among judges, including U.S. Supreme Court Justices, about the constitutional implications of allowing private citizens to represent the government in fraud cases.

  • Future Considerations: The 11th U.S. Circuit Court of Appeals is set to review a ruling that challenges the constitutionality of the False Claims Act, indicating a potential shift in how such cases may be handled in the future.

[object Object]
Preview
4.5
10-30Benzinga
S&P 500 Surpasses 6,900 Before Fed Rate Decision, Gold Recovers to $4,000: Market Movers for Wednesday

  • AI Stock Surge: A significant rise in AI-related stocks, particularly NVIDIA's 9% increase, has driven the S&P 500 and Nasdaq 100 to record highs, as investors anticipate the Federal Reserve's upcoming rate decision.

  • NVIDIA Milestone: NVIDIA became the first company to exceed a $5 trillion market valuation, contributing to a combined worth of $22.2 trillion for the "Magnificent Seven" tech companies, while announcing over $500 billion in data center orders.

  • Market Reactions: The iShares Semiconductor ETF (SOXX) has shown strong performance, and Caterpillar's stock surged 13% after positive earnings, while Fiserv's stock plummeted over 40% due to missed profit estimates.

  • Commodity Movements: Precious metals saw a rebound ahead of the Fed's decision, with silver and gold prices rising, while oil and natural gas also experienced significant price increases.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Encompass Health Corp (EHC) stock price today?

The current price of EHC is 114.8 USD — it has decreased -0.69 % in the last trading day.

arrow icon

What is Encompass Health Corp (EHC)'s business?

Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. It operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. It operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. It provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.

arrow icon

What is the price predicton of EHC Stock?

Wall Street analysts forecast EHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EHC is 142.57 USD with a low forecast of 134.00 USD and a high forecast of 160.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Encompass Health Corp (EHC)'s revenue for the last quarter?

Encompass Health Corp revenue for the last quarter amounts to 1.48B USD, increased 9.36 % YoY.

arrow icon

What is Encompass Health Corp (EHC)'s earnings per share (EPS) for the last quarter?

Encompass Health Corp. EPS for the last quarter amounts to 1.23 USD, increased 17.14 % YoY.

arrow icon

What changes have occurred in the market's expectations for Encompass Health Corp (EHC)'s fundamentals?

The market is revising Downward the revenue expectations for Encompass Health Corporation (EHC) for FY2025, with the revenue forecasts being adjusted by -0.06% over the past three months. During the same period, the stock price has changed by -3.63%.
arrow icon

How many employees does Encompass Health Corp (EHC). have?

Encompass Health Corp (EHC) has 23564 emplpoyees as of November 13 2025.

arrow icon

What is Encompass Health Corp (EHC) market cap?

Today EHC has the market capitalization of 11.55B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto Tracker
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free